nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—OPRD1—epilepsy syndrome	0.184	0.485	CbGaD
Oxycodone—OPRM1—epilepsy syndrome	0.141	0.371	CbGaD
Oxycodone—CYP2D6—epilepsy syndrome	0.0545	0.144	CbGaD
Oxycodone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0224	0.0629	CbGbCtD
Oxycodone—CYP3A7—Carbamazepine—epilepsy syndrome	0.0188	0.0526	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0188	0.0526	CbGbCtD
Oxycodone—CYP3A7—Phenytoin—epilepsy syndrome	0.0168	0.0472	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0168	0.0472	CbGbCtD
Oxycodone—CYP3A7—Phenobarbital—epilepsy syndrome	0.015	0.0421	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.015	0.0421	CbGbCtD
Oxycodone—CYP3A7—Midazolam—epilepsy syndrome	0.0148	0.0415	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0148	0.0415	CbGbCtD
Oxycodone—CYP3A7—Diazepam—epilepsy syndrome	0.0142	0.0399	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.0142	0.0399	CbGbCtD
Oxycodone—CYP3A5—Carbamazepine—epilepsy syndrome	0.0141	0.0395	CbGbCtD
Oxycodone—CYP3A5—Phenytoin—epilepsy syndrome	0.0126	0.0354	CbGbCtD
Oxycodone—CYP3A5—Phenobarbital—epilepsy syndrome	0.0112	0.0316	CbGbCtD
Oxycodone—CYP3A5—Midazolam—epilepsy syndrome	0.0111	0.0311	CbGbCtD
Oxycodone—CYP3A5—Diazepam—epilepsy syndrome	0.0107	0.0299	CbGbCtD
Oxycodone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00874	0.0245	CbGbCtD
Oxycodone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00841	0.0236	CbGbCtD
Oxycodone—CYP3A4—Trimethadione—epilepsy syndrome	0.00812	0.0228	CbGbCtD
Oxycodone—CYP3A4—Felbamate—epilepsy syndrome	0.00812	0.0228	CbGbCtD
Oxycodone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00764	0.0214	CbGbCtD
Oxycodone—CYP2D6—Propofol—epilepsy syndrome	0.00722	0.0203	CbGbCtD
Oxycodone—CYP3A4—Clonazepam—epilepsy syndrome	0.00691	0.0194	CbGbCtD
Oxycodone—CYP3A4—Clobazam—epilepsy syndrome	0.00662	0.0186	CbGbCtD
Oxycodone—CYP3A4—Rufinamide—epilepsy syndrome	0.00563	0.0158	CbGbCtD
Oxycodone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00549	0.0154	CbGbCtD
Oxycodone—CYP3A4—Primidone—epilepsy syndrome	0.00512	0.0144	CbGbCtD
Oxycodone—CYP3A4—Phenytoin—epilepsy syndrome	0.00492	0.0138	CbGbCtD
Oxycodone—CYP3A4—Propofol—epilepsy syndrome	0.00459	0.0129	CbGbCtD
Oxycodone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00439	0.0123	CbGbCtD
Oxycodone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00439	0.0123	CbGbCtD
Oxycodone—CYP3A4—Midazolam—epilepsy syndrome	0.00432	0.0121	CbGbCtD
Oxycodone—CYP3A4—Diazepam—epilepsy syndrome	0.00416	0.0117	CbGbCtD
Oxycodone—CYP3A4—Zonisamide—epilepsy syndrome	0.00406	0.0114	CbGbCtD
Oxycodone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00328	0.0092	CbGbCtD
Oxycodone—CYP3A4—Topiramate—epilepsy syndrome	0.00296	0.0083	CbGbCtD
Oxycodone—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00212	0.127	CbGeAlD
Oxycodone—OPRD1—ganglion—epilepsy syndrome	0.00193	0.116	CbGeAlD
Oxycodone—OPRM1—ganglion—epilepsy syndrome	0.00132	0.0789	CbGeAlD
Oxycodone—OPRD1—forebrain—epilepsy syndrome	0.000811	0.0485	CbGeAlD
Oxycodone—OPRK1—forebrain—epilepsy syndrome	0.000778	0.0465	CbGeAlD
Oxycodone—OPRD1—telencephalon—epilepsy syndrome	0.000746	0.0446	CbGeAlD
Oxycodone—OPRM1—brainstem—epilepsy syndrome	0.000573	0.0343	CbGeAlD
Oxycodone—OPRM1—forebrain—epilepsy syndrome	0.000553	0.0331	CbGeAlD
Oxycodone—OPRM1—telencephalon—epilepsy syndrome	0.000509	0.0304	CbGeAlD
Oxycodone—OPRD1—head—epilepsy syndrome	0.000465	0.0278	CbGeAlD
Oxycodone—OPRK1—head—epilepsy syndrome	0.000445	0.0266	CbGeAlD
Oxycodone—OPRD1—nervous system—epilepsy syndrome	0.00044	0.0263	CbGeAlD
Oxycodone—OPRD1—central nervous system—epilepsy syndrome	0.000424	0.0254	CbGeAlD
Oxycodone—OPRK1—nervous system—epilepsy syndrome	0.000422	0.0252	CbGeAlD
Oxycodone—OPRK1—central nervous system—epilepsy syndrome	0.000407	0.0243	CbGeAlD
Oxycodone—CYP2D6—hindbrain—epilepsy syndrome	0.000401	0.024	CbGeAlD
Oxycodone—OPRK1—cerebellum—epilepsy syndrome	0.000397	0.0238	CbGeAlD
Oxycodone—OPRM1—midbrain—epilepsy syndrome	0.000365	0.0218	CbGeAlD
Oxycodone—OPRM1—spinal cord—epilepsy syndrome	0.000356	0.0213	CbGeAlD
Oxycodone—OPRD1—brain—epilepsy syndrome	0.000337	0.0201	CbGeAlD
Oxycodone—OPRK1—brain—epilepsy syndrome	0.000323	0.0193	CbGeAlD
Oxycodone—OPRM1—head—epilepsy syndrome	0.000317	0.0189	CbGeAlD
Oxycodone—OPRM1—nervous system—epilepsy syndrome	0.0003	0.018	CbGeAlD
Oxycodone—OPRM1—central nervous system—epilepsy syndrome	0.000289	0.0173	CbGeAlD
Oxycodone—Galantamine—CHRNA2—epilepsy syndrome	0.000256	0.0581	CrCbGaD
Oxycodone—Nalbuphine—OPRD1—epilepsy syndrome	0.000251	0.0569	CrCbGaD
Oxycodone—Galantamine—CHRNB2—epilepsy syndrome	0.000251	0.0569	CrCbGaD
Oxycodone—CYP2D6—brainstem—epilepsy syndrome	0.00023	0.0137	CbGeAlD
Oxycodone—OPRM1—brain—epilepsy syndrome	0.00023	0.0137	CbGeAlD
Oxycodone—CYP2D6—forebrain—epilepsy syndrome	0.000222	0.0133	CbGeAlD
Oxycodone—Methylnaltrexone—OPRM1—epilepsy syndrome	0.00021	0.0476	CrCbGaD
Oxycodone—Naltrexone—OPRD1—epilepsy syndrome	0.000204	0.0464	CrCbGaD
Oxycodone—Oxymorphone—OPRD1—epilepsy syndrome	0.000204	0.0464	CrCbGaD
Oxycodone—CYP2D6—telencephalon—epilepsy syndrome	0.000204	0.0122	CbGeAlD
Oxycodone—Nalbuphine—OPRM1—epilepsy syndrome	0.000192	0.0436	CrCbGaD
Oxycodone—Naloxone—SLCO1A2—epilepsy syndrome	0.000179	0.0407	CrCbGaD
Oxycodone—Hydrocodone—OPRD1—epilepsy syndrome	0.000179	0.0406	CrCbGaD
Oxycodone—Dihydrocodeine—OPRM1—epilepsy syndrome	0.000178	0.0405	CrCbGaD
Oxycodone—Oxymorphone—OPRM1—epilepsy syndrome	0.000156	0.0355	CrCbGaD
Oxycodone—Naltrexone—OPRM1—epilepsy syndrome	0.000156	0.0355	CrCbGaD
Oxycodone—Codeine—OPRD1—epilepsy syndrome	0.000155	0.0353	CrCbGaD
Oxycodone—Ethylmorphine—OPRM1—epilepsy syndrome	0.000149	0.0339	CrCbGaD
Oxycodone—Naloxone—OPRD1—epilepsy syndrome	0.000149	0.0339	CrCbGaD
Oxycodone—Hydromorphone—OPRD1—epilepsy syndrome	0.000148	0.0336	CrCbGaD
Oxycodone—Galantamine—CHRNA7—epilepsy syndrome	0.000147	0.0334	CrCbGaD
Oxycodone—Hydrocodone—OPRM1—epilepsy syndrome	0.000137	0.031	CrCbGaD
Oxycodone—CYP2D6—head—epilepsy syndrome	0.000127	0.00759	CbGeAlD
Oxycodone—CYP3A4—nervous system—epilepsy syndrome	0.000122	0.00732	CbGeAlD
Oxycodone—CYP2D6—nervous system—epilepsy syndrome	0.00012	0.0072	CbGeAlD
Oxycodone—Codeine—OPRM1—epilepsy syndrome	0.000119	0.027	CrCbGaD
Oxycodone—CYP3A4—central nervous system—epilepsy syndrome	0.000118	0.00704	CbGeAlD
Oxycodone—Galantamine—CHRNA4—epilepsy syndrome	0.000117	0.0267	CrCbGaD
Oxycodone—CYP2D6—central nervous system—epilepsy syndrome	0.000116	0.00693	CbGeAlD
Oxycodone—Naloxone—OPRM1—epilepsy syndrome	0.000114	0.0259	CrCbGaD
Oxycodone—CYP2D6—cerebellum—epilepsy syndrome	0.000113	0.00678	CbGeAlD
Oxycodone—Hydromorphone—OPRM1—epilepsy syndrome	0.000113	0.0257	CrCbGaD
Oxycodone—CYP2D6—brain—epilepsy syndrome	9.2e-05	0.0055	CbGeAlD
Oxycodone—Methylnaltrexone—CYP2D6—epilepsy syndrome	8.12e-05	0.0184	CrCbGaD
Oxycodone—Galantamine—BCHE—epilepsy syndrome	7.62e-05	0.0173	CrCbGaD
Oxycodone—Dihydrocodeine—CYP2D6—epilepsy syndrome	6.9e-05	0.0157	CrCbGaD
Oxycodone—Oxymorphone—CYP2D6—epilepsy syndrome	6.05e-05	0.0137	CrCbGaD
Oxycodone—Ethylmorphine—CYP2D6—epilepsy syndrome	5.79e-05	0.0131	CrCbGaD
Oxycodone—Hydrocodone—CYP2D6—epilepsy syndrome	5.29e-05	0.012	CrCbGaD
Oxycodone—Codeine—CYP2D6—epilepsy syndrome	4.61e-05	0.0105	CrCbGaD
Oxycodone—Hydromorphone—CYP2D6—epilepsy syndrome	4.38e-05	0.00996	CrCbGaD
Oxycodone—Naltrexone—ABCB1—epilepsy syndrome	4.32e-05	0.00982	CrCbGaD
Oxycodone—Galantamine—CYP2D6—epilepsy syndrome	4.18e-05	0.0095	CrCbGaD
Oxycodone—Naloxone—ALB—epilepsy syndrome	3.3e-05	0.00751	CrCbGaD
Oxycodone—Naloxone—ABCB1—epilepsy syndrome	3.15e-05	0.00716	CrCbGaD
Oxycodone—Myalgia—Pregabalin—epilepsy syndrome	2.3e-05	0.000124	CcSEcCtD
Oxycodone—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.3e-05	0.000124	CcSEcCtD
Oxycodone—Dizziness—Zonisamide—epilepsy syndrome	2.3e-05	0.000124	CcSEcCtD
Oxycodone—Headache—Diazepam—epilepsy syndrome	2.3e-05	0.000124	CcSEcCtD
Oxycodone—Anxiety—Pregabalin—epilepsy syndrome	2.29e-05	0.000124	CcSEcCtD
Oxycodone—Diarrhoea—Clonazepam—epilepsy syndrome	2.29e-05	0.000124	CcSEcCtD
Oxycodone—Anaemia—Gabapentin—epilepsy syndrome	2.29e-05	0.000124	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.29e-05	0.000124	CcSEcCtD
Oxycodone—Hypotension—Valproic Acid—epilepsy syndrome	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Asthenia—Carbamazepine—epilepsy syndrome	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Agitation—Gabapentin—epilepsy syndrome	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Diarrhoea—Phenytoin—epilepsy syndrome	2.28e-05	0.000123	CcSEcCtD
Oxycodone—Discomfort—Pregabalin—epilepsy syndrome	2.27e-05	0.000123	CcSEcCtD
Oxycodone—Nausea—Fosphenytoin—epilepsy syndrome	2.27e-05	0.000123	CcSEcCtD
Oxycodone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.000122	CcSEcCtD
Oxycodone—Angioedema—Gabapentin—epilepsy syndrome	2.27e-05	0.000122	CcSEcCtD
Oxycodone—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.26e-05	0.000122	CcSEcCtD
Oxycodone—Vomiting—Felbamate—epilepsy syndrome	2.26e-05	0.000122	CcSEcCtD
Oxycodone—Dry mouth—Pregabalin—epilepsy syndrome	2.25e-05	0.000122	CcSEcCtD
Oxycodone—Pruritus—Carbamazepine—epilepsy syndrome	2.25e-05	0.000121	CcSEcCtD
Oxycodone—Rash—Felbamate—epilepsy syndrome	2.24e-05	0.000121	CcSEcCtD
Oxycodone—Eye disorder—Topiramate—epilepsy syndrome	2.24e-05	0.000121	CcSEcCtD
Oxycodone—Dermatitis—Felbamate—epilepsy syndrome	2.24e-05	0.000121	CcSEcCtD
Oxycodone—Malaise—Gabapentin—epilepsy syndrome	2.24e-05	0.000121	CcSEcCtD
Oxycodone—Tinnitus—Topiramate—epilepsy syndrome	2.23e-05	0.000121	CcSEcCtD
Oxycodone—Vertigo—Gabapentin—epilepsy syndrome	2.23e-05	0.00012	CcSEcCtD
Oxycodone—Headache—Felbamate—epilepsy syndrome	2.23e-05	0.00012	CcSEcCtD
Oxycodone—Confusional state—Pregabalin—epilepsy syndrome	2.23e-05	0.00012	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Cardiac disorder—Topiramate—epilepsy syndrome	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Flushing—Topiramate—epilepsy syndrome	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Syncope—Gabapentin—epilepsy syndrome	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Leukopenia—Gabapentin—epilepsy syndrome	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Dizziness—Clonazepam—epilepsy syndrome	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Nausea—Vigabatrin—epilepsy syndrome	2.22e-05	0.00012	CcSEcCtD
Oxycodone—Vomiting—Zonisamide—epilepsy syndrome	2.21e-05	0.000119	CcSEcCtD
Oxycodone—Insomnia—Valproic Acid—epilepsy syndrome	2.21e-05	0.000119	CcSEcCtD
Oxycodone—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.21e-05	0.000119	CcSEcCtD
Oxycodone—Oedema—Pregabalin—epilepsy syndrome	2.21e-05	0.000119	CcSEcCtD
Oxycodone—Asthenia—Lamotrigine—epilepsy syndrome	2.2e-05	0.000119	CcSEcCtD
Oxycodone—Dizziness—Phenytoin—epilepsy syndrome	2.2e-05	0.000119	CcSEcCtD
Oxycodone—Rash—Zonisamide—epilepsy syndrome	2.19e-05	0.000118	CcSEcCtD
Oxycodone—Infection—Pregabalin—epilepsy syndrome	2.19e-05	0.000118	CcSEcCtD
Oxycodone—Paraesthesia—Valproic Acid—epilepsy syndrome	2.19e-05	0.000118	CcSEcCtD
Oxycodone—Palpitations—Gabapentin—epilepsy syndrome	2.19e-05	0.000118	CcSEcCtD
Oxycodone—Dermatitis—Zonisamide—epilepsy syndrome	2.19e-05	0.000118	CcSEcCtD
Oxycodone—Dizziness—Oxcarbazepine—epilepsy syndrome	2.19e-05	0.000118	CcSEcCtD
Oxycodone—Nausea—Diazepam—epilepsy syndrome	2.18e-05	0.000118	CcSEcCtD
Oxycodone—Loss of consciousness—Gabapentin—epilepsy syndrome	2.18e-05	0.000118	CcSEcCtD
Oxycodone—Headache—Zonisamide—epilepsy syndrome	2.18e-05	0.000118	CcSEcCtD
Oxycodone—Dyspnoea—Valproic Acid—epilepsy syndrome	2.18e-05	0.000118	CcSEcCtD
Oxycodone—Diarrhoea—Carbamazepine—epilepsy syndrome	2.17e-05	0.000117	CcSEcCtD
Oxycodone—Angiopathy—Topiramate—epilepsy syndrome	2.17e-05	0.000117	CcSEcCtD
Oxycodone—Pruritus—Lamotrigine—epilepsy syndrome	2.17e-05	0.000117	CcSEcCtD
Oxycodone—Shock—Pregabalin—epilepsy syndrome	2.17e-05	0.000117	CcSEcCtD
Oxycodone—Somnolence—Valproic Acid—epilepsy syndrome	2.17e-05	0.000117	CcSEcCtD
Oxycodone—Immune system disorder—Topiramate—epilepsy syndrome	2.16e-05	0.000117	CcSEcCtD
Oxycodone—Nervous system disorder—Pregabalin—epilepsy syndrome	2.16e-05	0.000117	CcSEcCtD
Oxycodone—Cough—Gabapentin—epilepsy syndrome	2.16e-05	0.000117	CcSEcCtD
Oxycodone—Mediastinal disorder—Topiramate—epilepsy syndrome	2.16e-05	0.000117	CcSEcCtD
Oxycodone—Tachycardia—Pregabalin—epilepsy syndrome	2.15e-05	0.000116	CcSEcCtD
Oxycodone—Chills—Topiramate—epilepsy syndrome	2.15e-05	0.000116	CcSEcCtD
Oxycodone—Dyspepsia—Valproic Acid—epilepsy syndrome	2.15e-05	0.000116	CcSEcCtD
Oxycodone—Convulsion—Gabapentin—epilepsy syndrome	2.15e-05	0.000116	CcSEcCtD
Oxycodone—Skin disorder—Pregabalin—epilepsy syndrome	2.14e-05	0.000116	CcSEcCtD
Oxycodone—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.13e-05	0.000115	CcSEcCtD
Oxycodone—Vomiting—Clonazepam—epilepsy syndrome	2.13e-05	0.000115	CcSEcCtD
Oxycodone—Decreased appetite—Valproic Acid—epilepsy syndrome	2.12e-05	0.000115	CcSEcCtD
Oxycodone—Vomiting—Phenytoin—epilepsy syndrome	2.12e-05	0.000114	CcSEcCtD
Oxycodone—Rash—Clonazepam—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Dermatitis—Clonazepam—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Chest pain—Gabapentin—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Arthralgia—Gabapentin—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Myalgia—Gabapentin—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Nausea—Felbamate—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Vomiting—Oxcarbazepine—epilepsy syndrome	2.11e-05	0.000114	CcSEcCtD
Oxycodone—Fatigue—Valproic Acid—epilepsy syndrome	2.1e-05	0.000114	CcSEcCtD
Oxycodone—Anxiety—Gabapentin—epilepsy syndrome	2.1e-05	0.000114	CcSEcCtD
Oxycodone—Anorexia—Pregabalin—epilepsy syndrome	2.1e-05	0.000114	CcSEcCtD
Oxycodone—Dizziness—Carbamazepine—epilepsy syndrome	2.1e-05	0.000114	CcSEcCtD
Oxycodone—Diarrhoea—Lamotrigine—epilepsy syndrome	2.1e-05	0.000114	CcSEcCtD
Oxycodone—Headache—Clonazepam—epilepsy syndrome	2.1e-05	0.000113	CcSEcCtD
Oxycodone—Rash—Phenytoin—epilepsy syndrome	2.1e-05	0.000113	CcSEcCtD
Oxycodone—Mental disorder—Topiramate—epilepsy syndrome	2.1e-05	0.000113	CcSEcCtD
Oxycodone—Dermatitis—Phenytoin—epilepsy syndrome	2.1e-05	0.000113	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.1e-05	0.000113	CcSEcCtD
Oxycodone—Rash—Oxcarbazepine—epilepsy syndrome	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Pain—Valproic Acid—epilepsy syndrome	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Constipation—Valproic Acid—epilepsy syndrome	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Headache—Phenytoin—epilepsy syndrome	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Malnutrition—Topiramate—epilepsy syndrome	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Discomfort—Gabapentin—epilepsy syndrome	2.09e-05	0.000113	CcSEcCtD
Oxycodone—Headache—Oxcarbazepine—epilepsy syndrome	2.08e-05	0.000112	CcSEcCtD
Oxycodone—Nausea—Zonisamide—epilepsy syndrome	2.07e-05	0.000112	CcSEcCtD
Oxycodone—Dry mouth—Gabapentin—epilepsy syndrome	2.06e-05	0.000112	CcSEcCtD
Oxycodone—Hypotension—Pregabalin—epilepsy syndrome	2.06e-05	0.000111	CcSEcCtD
Oxycodone—Flatulence—Topiramate—epilepsy syndrome	2.06e-05	0.000111	CcSEcCtD
Oxycodone—Tension—Topiramate—epilepsy syndrome	2.05e-05	0.000111	CcSEcCtD
Oxycodone—Dysgeusia—Topiramate—epilepsy syndrome	2.04e-05	0.00011	CcSEcCtD
Oxycodone—Confusional state—Gabapentin—epilepsy syndrome	2.04e-05	0.00011	CcSEcCtD
Oxycodone—Dizziness—Lamotrigine—epilepsy syndrome	2.03e-05	0.00011	CcSEcCtD
Oxycodone—Nervousness—Topiramate—epilepsy syndrome	2.03e-05	0.000109	CcSEcCtD
Oxycodone—Oedema—Gabapentin—epilepsy syndrome	2.02e-05	0.000109	CcSEcCtD
Oxycodone—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.02e-05	0.000109	CcSEcCtD
Oxycodone—Vomiting—Carbamazepine—epilepsy syndrome	2.02e-05	0.000109	CcSEcCtD
Oxycodone—Back pain—Topiramate—epilepsy syndrome	2.02e-05	0.000109	CcSEcCtD
Oxycodone—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.01e-05	0.000109	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.01e-05	0.000109	CcSEcCtD
Oxycodone—Infection—Gabapentin—epilepsy syndrome	2.01e-05	0.000109	CcSEcCtD
Oxycodone—Muscle spasms—Topiramate—epilepsy syndrome	2.01e-05	0.000108	CcSEcCtD
Oxycodone—Rash—Carbamazepine—epilepsy syndrome	2e-05	0.000108	CcSEcCtD
Oxycodone—Dermatitis—Carbamazepine—epilepsy syndrome	2e-05	0.000108	CcSEcCtD
Oxycodone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2e-05	0.000108	CcSEcCtD
Oxycodone—Insomnia—Pregabalin—epilepsy syndrome	2e-05	0.000108	CcSEcCtD
Oxycodone—Nausea—Clonazepam—epilepsy syndrome	1.99e-05	0.000108	CcSEcCtD
Oxycodone—Headache—Carbamazepine—epilepsy syndrome	1.99e-05	0.000108	CcSEcCtD
Oxycodone—Shock—Gabapentin—epilepsy syndrome	1.99e-05	0.000108	CcSEcCtD
Oxycodone—Nervous system disorder—Gabapentin—epilepsy syndrome	1.98e-05	0.000107	CcSEcCtD
Oxycodone—Paraesthesia—Pregabalin—epilepsy syndrome	1.98e-05	0.000107	CcSEcCtD
Oxycodone—Nausea—Phenytoin—epilepsy syndrome	1.98e-05	0.000107	CcSEcCtD
Oxycodone—Tachycardia—Gabapentin—epilepsy syndrome	1.98e-05	0.000107	CcSEcCtD
Oxycodone—Dyspnoea—Pregabalin—epilepsy syndrome	1.97e-05	0.000106	CcSEcCtD
Oxycodone—Nausea—Oxcarbazepine—epilepsy syndrome	1.97e-05	0.000106	CcSEcCtD
Oxycodone—Skin disorder—Gabapentin—epilepsy syndrome	1.97e-05	0.000106	CcSEcCtD
Oxycodone—Somnolence—Pregabalin—epilepsy syndrome	1.96e-05	0.000106	CcSEcCtD
Oxycodone—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.96e-05	0.000106	CcSEcCtD
Oxycodone—Tremor—Topiramate—epilepsy syndrome	1.95e-05	0.000106	CcSEcCtD
Oxycodone—Vomiting—Lamotrigine—epilepsy syndrome	1.95e-05	0.000106	CcSEcCtD
Oxycodone—Urticaria—Valproic Acid—epilepsy syndrome	1.94e-05	0.000105	CcSEcCtD
Oxycodone—Rash—Lamotrigine—epilepsy syndrome	1.94e-05	0.000105	CcSEcCtD
Oxycodone—Ill-defined disorder—Topiramate—epilepsy syndrome	1.94e-05	0.000105	CcSEcCtD
Oxycodone—Dermatitis—Lamotrigine—epilepsy syndrome	1.94e-05	0.000105	CcSEcCtD
Oxycodone—Abdominal pain—Valproic Acid—epilepsy syndrome	1.93e-05	0.000104	CcSEcCtD
Oxycodone—Body temperature increased—Valproic Acid—epilepsy syndrome	1.93e-05	0.000104	CcSEcCtD
Oxycodone—Anorexia—Gabapentin—epilepsy syndrome	1.93e-05	0.000104	CcSEcCtD
Oxycodone—Anaemia—Topiramate—epilepsy syndrome	1.93e-05	0.000104	CcSEcCtD
Oxycodone—Headache—Lamotrigine—epilepsy syndrome	1.92e-05	0.000104	CcSEcCtD
Oxycodone—Decreased appetite—Pregabalin—epilepsy syndrome	1.92e-05	0.000104	CcSEcCtD
Oxycodone—Agitation—Topiramate—epilepsy syndrome	1.92e-05	0.000104	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.91e-05	0.000103	CcSEcCtD
Oxycodone—Fatigue—Pregabalin—epilepsy syndrome	1.9e-05	0.000103	CcSEcCtD
Oxycodone—Hypotension—Gabapentin—epilepsy syndrome	1.89e-05	0.000102	CcSEcCtD
Oxycodone—Nausea—Carbamazepine—epilepsy syndrome	1.89e-05	0.000102	CcSEcCtD
Oxycodone—Pain—Pregabalin—epilepsy syndrome	1.89e-05	0.000102	CcSEcCtD
Oxycodone—Constipation—Pregabalin—epilepsy syndrome	1.89e-05	0.000102	CcSEcCtD
Oxycodone—Malaise—Topiramate—epilepsy syndrome	1.88e-05	0.000102	CcSEcCtD
Oxycodone—Vertigo—Topiramate—epilepsy syndrome	1.87e-05	0.000101	CcSEcCtD
Oxycodone—Syncope—Topiramate—epilepsy syndrome	1.87e-05	0.000101	CcSEcCtD
Oxycodone—Leukopenia—Topiramate—epilepsy syndrome	1.87e-05	0.000101	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.84e-05	9.96e-05	CcSEcCtD
Oxycodone—Palpitations—Topiramate—epilepsy syndrome	1.84e-05	9.96e-05	CcSEcCtD
Oxycodone—Loss of consciousness—Topiramate—epilepsy syndrome	1.83e-05	9.91e-05	CcSEcCtD
Oxycodone—Insomnia—Gabapentin—epilepsy syndrome	1.83e-05	9.89e-05	CcSEcCtD
Oxycodone—Nausea—Lamotrigine—epilepsy syndrome	1.82e-05	9.86e-05	CcSEcCtD
Oxycodone—Cough—Topiramate—epilepsy syndrome	1.82e-05	9.83e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Pregabalin—epilepsy syndrome	1.82e-05	9.82e-05	CcSEcCtD
Oxycodone—Paraesthesia—Gabapentin—epilepsy syndrome	1.82e-05	9.82e-05	CcSEcCtD
Oxycodone—Convulsion—Topiramate—epilepsy syndrome	1.81e-05	9.76e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.8e-05	9.75e-05	CcSEcCtD
Oxycodone—Dyspnoea—Gabapentin—epilepsy syndrome	1.8e-05	9.75e-05	CcSEcCtD
Oxycodone—Somnolence—Gabapentin—epilepsy syndrome	1.8e-05	9.72e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.8e-05	9.72e-05	CcSEcCtD
Oxycodone—Dyspepsia—Gabapentin—epilepsy syndrome	1.78e-05	9.62e-05	CcSEcCtD
Oxycodone—Arthralgia—Topiramate—epilepsy syndrome	1.78e-05	9.59e-05	CcSEcCtD
Oxycodone—Chest pain—Topiramate—epilepsy syndrome	1.78e-05	9.59e-05	CcSEcCtD
Oxycodone—Myalgia—Topiramate—epilepsy syndrome	1.78e-05	9.59e-05	CcSEcCtD
Oxycodone—Anxiety—Topiramate—epilepsy syndrome	1.77e-05	9.56e-05	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.76e-05	9.53e-05	CcSEcCtD
Oxycodone—Decreased appetite—Gabapentin—epilepsy syndrome	1.76e-05	9.5e-05	CcSEcCtD
Oxycodone—Discomfort—Topiramate—epilepsy syndrome	1.75e-05	9.48e-05	CcSEcCtD
Oxycodone—Urticaria—Pregabalin—epilepsy syndrome	1.75e-05	9.47e-05	CcSEcCtD
Oxycodone—Asthenia—Valproic Acid—epilepsy syndrome	1.75e-05	9.46e-05	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.75e-05	9.44e-05	CcSEcCtD
Oxycodone—Fatigue—Gabapentin—epilepsy syndrome	1.74e-05	9.43e-05	CcSEcCtD
Oxycodone—Abdominal pain—Pregabalin—epilepsy syndrome	1.74e-05	9.42e-05	CcSEcCtD
Oxycodone—Body temperature increased—Pregabalin—epilepsy syndrome	1.74e-05	9.42e-05	CcSEcCtD
Oxycodone—Dry mouth—Topiramate—epilepsy syndrome	1.74e-05	9.38e-05	CcSEcCtD
Oxycodone—Pain—Gabapentin—epilepsy syndrome	1.73e-05	9.35e-05	CcSEcCtD
Oxycodone—Constipation—Gabapentin—epilepsy syndrome	1.73e-05	9.35e-05	CcSEcCtD
Oxycodone—Pruritus—Valproic Acid—epilepsy syndrome	1.73e-05	9.33e-05	CcSEcCtD
Oxycodone—Confusional state—Topiramate—epilepsy syndrome	1.72e-05	9.27e-05	CcSEcCtD
Oxycodone—Oedema—Topiramate—epilepsy syndrome	1.7e-05	9.2e-05	CcSEcCtD
Oxycodone—Infection—Topiramate—epilepsy syndrome	1.69e-05	9.14e-05	CcSEcCtD
Oxycodone—Shock—Topiramate—epilepsy syndrome	1.68e-05	9.05e-05	CcSEcCtD
Oxycodone—Diarrhoea—Valproic Acid—epilepsy syndrome	1.67e-05	9.02e-05	CcSEcCtD
Oxycodone—Nervous system disorder—Topiramate—epilepsy syndrome	1.67e-05	9.02e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Gabapentin—epilepsy syndrome	1.67e-05	9.01e-05	CcSEcCtD
Oxycodone—Tachycardia—Topiramate—epilepsy syndrome	1.66e-05	8.98e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.65e-05	8.94e-05	CcSEcCtD
Oxycodone—Skin disorder—Topiramate—epilepsy syndrome	1.65e-05	8.93e-05	CcSEcCtD
Oxycodone—Hyperhidrosis—Topiramate—epilepsy syndrome	1.65e-05	8.89e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Pregabalin—epilepsy syndrome	1.63e-05	8.78e-05	CcSEcCtD
Oxycodone—Anorexia—Topiramate—epilepsy syndrome	1.62e-05	8.77e-05	CcSEcCtD
Oxycodone—Dizziness—Valproic Acid—epilepsy syndrome	1.61e-05	8.72e-05	CcSEcCtD
Oxycodone—Urticaria—Gabapentin—epilepsy syndrome	1.61e-05	8.69e-05	CcSEcCtD
Oxycodone—Body temperature increased—Gabapentin—epilepsy syndrome	1.6e-05	8.64e-05	CcSEcCtD
Oxycodone—Abdominal pain—Gabapentin—epilepsy syndrome	1.6e-05	8.64e-05	CcSEcCtD
Oxycodone—Hypotension—Topiramate—epilepsy syndrome	1.59e-05	8.59e-05	CcSEcCtD
Oxycodone—Asthenia—Pregabalin—epilepsy syndrome	1.58e-05	8.55e-05	CcSEcCtD
Oxycodone—Pruritus—Pregabalin—epilepsy syndrome	1.56e-05	8.44e-05	CcSEcCtD
Oxycodone—Vomiting—Valproic Acid—epilepsy syndrome	1.55e-05	8.38e-05	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.55e-05	8.38e-05	CcSEcCtD
Oxycodone—Insomnia—Topiramate—epilepsy syndrome	1.54e-05	8.32e-05	CcSEcCtD
Oxycodone—Rash—Valproic Acid—epilepsy syndrome	1.54e-05	8.32e-05	CcSEcCtD
Oxycodone—Dermatitis—Valproic Acid—epilepsy syndrome	1.54e-05	8.31e-05	CcSEcCtD
Oxycodone—Headache—Valproic Acid—epilepsy syndrome	1.53e-05	8.26e-05	CcSEcCtD
Oxycodone—Paraesthesia—Topiramate—epilepsy syndrome	1.53e-05	8.26e-05	CcSEcCtD
Oxycodone—Dyspnoea—Topiramate—epilepsy syndrome	1.52e-05	8.2e-05	CcSEcCtD
Oxycodone—Somnolence—Topiramate—epilepsy syndrome	1.51e-05	8.18e-05	CcSEcCtD
Oxycodone—Diarrhoea—Pregabalin—epilepsy syndrome	1.51e-05	8.16e-05	CcSEcCtD
Oxycodone—Dyspepsia—Topiramate—epilepsy syndrome	1.5e-05	8.1e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Gabapentin—epilepsy syndrome	1.49e-05	8.05e-05	CcSEcCtD
Oxycodone—Decreased appetite—Topiramate—epilepsy syndrome	1.48e-05	8e-05	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.47e-05	7.94e-05	CcSEcCtD
Oxycodone—Fatigue—Topiramate—epilepsy syndrome	1.47e-05	7.93e-05	CcSEcCtD
Oxycodone—Dizziness—Pregabalin—epilepsy syndrome	1.46e-05	7.88e-05	CcSEcCtD
Oxycodone—Pain—Topiramate—epilepsy syndrome	1.46e-05	7.87e-05	CcSEcCtD
Oxycodone—Constipation—Topiramate—epilepsy syndrome	1.46e-05	7.87e-05	CcSEcCtD
Oxycodone—Asthenia—Gabapentin—epilepsy syndrome	1.45e-05	7.84e-05	CcSEcCtD
Oxycodone—Nausea—Valproic Acid—epilepsy syndrome	1.45e-05	7.83e-05	CcSEcCtD
Oxycodone—Pruritus—Gabapentin—epilepsy syndrome	1.43e-05	7.73e-05	CcSEcCtD
Oxycodone—Vomiting—Pregabalin—epilepsy syndrome	1.4e-05	7.58e-05	CcSEcCtD
Oxycodone—Feeling abnormal—Topiramate—epilepsy syndrome	1.4e-05	7.58e-05	CcSEcCtD
Oxycodone—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.39e-05	7.52e-05	CcSEcCtD
Oxycodone—Rash—Pregabalin—epilepsy syndrome	1.39e-05	7.52e-05	CcSEcCtD
Oxycodone—Dermatitis—Pregabalin—epilepsy syndrome	1.39e-05	7.51e-05	CcSEcCtD
Oxycodone—Diarrhoea—Gabapentin—epilepsy syndrome	1.38e-05	7.48e-05	CcSEcCtD
Oxycodone—Headache—Pregabalin—epilepsy syndrome	1.38e-05	7.47e-05	CcSEcCtD
Oxycodone—Urticaria—Topiramate—epilepsy syndrome	1.35e-05	7.31e-05	CcSEcCtD
Oxycodone—Abdominal pain—Topiramate—epilepsy syndrome	1.35e-05	7.27e-05	CcSEcCtD
Oxycodone—Body temperature increased—Topiramate—epilepsy syndrome	1.35e-05	7.27e-05	CcSEcCtD
Oxycodone—Dizziness—Gabapentin—epilepsy syndrome	1.34e-05	7.23e-05	CcSEcCtD
Oxycodone—Nausea—Pregabalin—epilepsy syndrome	1.31e-05	7.08e-05	CcSEcCtD
Oxycodone—Vomiting—Gabapentin—epilepsy syndrome	1.29e-05	6.95e-05	CcSEcCtD
Oxycodone—Rash—Gabapentin—epilepsy syndrome	1.28e-05	6.89e-05	CcSEcCtD
Oxycodone—Dermatitis—Gabapentin—epilepsy syndrome	1.27e-05	6.89e-05	CcSEcCtD
Oxycodone—Headache—Gabapentin—epilepsy syndrome	1.27e-05	6.85e-05	CcSEcCtD
Oxycodone—Hypersensitivity—Topiramate—epilepsy syndrome	1.25e-05	6.78e-05	CcSEcCtD
Oxycodone—Asthenia—Topiramate—epilepsy syndrome	1.22e-05	6.6e-05	CcSEcCtD
Oxycodone—Pruritus—Topiramate—epilepsy syndrome	1.2e-05	6.51e-05	CcSEcCtD
Oxycodone—Nausea—Gabapentin—epilepsy syndrome	1.2e-05	6.49e-05	CcSEcCtD
Oxycodone—Diarrhoea—Topiramate—epilepsy syndrome	1.16e-05	6.29e-05	CcSEcCtD
Oxycodone—Dizziness—Topiramate—epilepsy syndrome	1.13e-05	6.08e-05	CcSEcCtD
Oxycodone—Vomiting—Topiramate—epilepsy syndrome	1.08e-05	5.85e-05	CcSEcCtD
Oxycodone—Rash—Topiramate—epilepsy syndrome	1.07e-05	5.8e-05	CcSEcCtD
Oxycodone—Dermatitis—Topiramate—epilepsy syndrome	1.07e-05	5.79e-05	CcSEcCtD
Oxycodone—Headache—Topiramate—epilepsy syndrome	1.07e-05	5.76e-05	CcSEcCtD
Oxycodone—Nausea—Topiramate—epilepsy syndrome	1.01e-05	5.46e-05	CcSEcCtD
Oxycodone—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	7.16e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.14e-06	0.000122	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.11e-06	0.000121	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.11e-06	0.000121	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.11e-06	0.000121	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.11e-06	0.000121	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CNR1—epilepsy syndrome	7.07e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JUNB—epilepsy syndrome	7.07e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	7.06e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PLCB1—epilepsy syndrome	7.04e-06	0.00012	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.01e-06	0.000119	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	6.94e-06	0.000118	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	6.94e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—S100B—epilepsy syndrome	6.92e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	6.91e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR7—epilepsy syndrome	6.9e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SOCS3—epilepsy syndrome	6.85e-06	0.000117	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP2D6—epilepsy syndrome	6.84e-06	0.000117	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDC42—epilepsy syndrome	6.84e-06	0.000116	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NT5E—epilepsy syndrome	6.83e-06	0.000116	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALAD—epilepsy syndrome	6.83e-06	0.000116	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HBEGF—epilepsy syndrome	6.69e-06	0.000114	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.67e-06	0.000114	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	6.65e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	6.65e-06	0.000113	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AVP—epilepsy syndrome	6.62e-06	0.000113	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.61e-06	0.000113	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.61e-06	0.000113	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.59e-06	0.000112	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT3—epilepsy syndrome	6.57e-06	0.000112	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	6.56e-06	0.000112	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—POMC—epilepsy syndrome	6.53e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADRA2A—epilepsy syndrome	6.52e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	6.51e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	6.51e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—BCHE—epilepsy syndrome	6.49e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	6.47e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	6.47e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SST—epilepsy syndrome	6.47e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ADAM10—epilepsy syndrome	6.42e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	6.42e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	6.39e-06	0.000109	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.38e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	6.33e-06	0.000108	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	6.31e-06	0.000107	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	6.26e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.25e-06	0.000106	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.21e-06	0.000106	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	6.19e-06	0.000105	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.13e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	6.12e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—TH—epilepsy syndrome	6.1e-06	0.000104	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	6.09e-06	0.000104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	6.09e-06	0.000104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	6.09e-06	0.000104	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	6.08e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	6.07e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	6.07e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	6.06e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	6.05e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	6.03e-06	0.000103	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.01e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	6.01e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	6e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	5.97e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	5.97e-06	0.000102	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	5.95e-06	0.000101	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.89e-06	0.0001	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.89e-06	0.0001	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.89e-06	0.0001	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.89e-06	0.0001	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.89e-06	0.0001	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.85e-06	9.96e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	5.83e-06	9.92e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	5.8e-06	9.88e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	5.79e-06	9.85e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	5.66e-06	9.63e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	5.66e-06	9.63e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	5.63e-06	9.58e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.62e-06	9.57e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	5.55e-06	9.45e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	5.52e-06	9.39e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	5.52e-06	9.39e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	5.51e-06	9.38e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	5.49e-06	9.34e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	5.48e-06	9.33e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.46e-06	9.29e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	5.42e-06	9.23e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	5.4e-06	9.19e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.39e-06	9.17e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.39e-06	9.17e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.39e-06	9.17e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	5.34e-06	9.09e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	5.32e-06	9.05e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	5.31e-06	9.04e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	5.23e-06	8.91e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	5.23e-06	8.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.19e-06	8.83e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.13e-06	8.73e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	5.13e-06	8.73e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	5.12e-06	8.72e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	5.09e-06	8.67e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	5.08e-06	8.65e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	5.07e-06	8.64e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	5.07e-06	8.63e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CAT—epilepsy syndrome	5.02e-06	8.55e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	5.02e-06	8.54e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.01e-06	8.53e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.01e-06	8.53e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	4.95e-06	8.42e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.94e-06	8.4e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.94e-06	8.4e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	4.94e-06	8.4e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	4.91e-06	8.35e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	4.89e-06	8.32e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	4.83e-06	8.22e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	4.83e-06	8.22e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	4.81e-06	8.19e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.71e-06	8.02e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	4.71e-06	8.02e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—BCHE—epilepsy syndrome	4.69e-06	7.98e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	4.64e-06	7.9e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	4.59e-06	7.81e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	4.58e-06	7.8e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.58e-06	7.8e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GPX1—epilepsy syndrome	4.54e-06	7.73e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	4.51e-06	7.68e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	4.49e-06	7.65e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	4.49e-06	7.64e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	4.49e-06	7.64e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	4.47e-06	7.62e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.46e-06	7.6e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.46e-06	7.6e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	4.43e-06	7.53e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TH—epilepsy syndrome	4.41e-06	7.51e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	4.4e-06	7.49e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	4.4e-06	7.49e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	4.34e-06	7.38e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	4.3e-06	7.33e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	4.29e-06	7.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.26e-06	7.25e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.26e-06	7.25e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	4.23e-06	7.21e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	4.22e-06	7.18e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	4.17e-06	7.1e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.17e-06	7.1e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.08e-06	6.95e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	4.08e-06	6.95e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.02e-06	6.85e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4e-06	6.82e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AGT—epilepsy syndrome	3.98e-06	6.78e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.93e-06	6.69e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.92e-06	6.68e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOE—epilepsy syndrome	3.9e-06	6.64e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.9e-06	6.64e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	3.89e-06	6.62e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.88e-06	6.6e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	3.87e-06	6.59e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	3.86e-06	6.57e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	3.79e-06	6.46e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	3.77e-06	6.42e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	3.72e-06	6.33e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	3.68e-06	6.26e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.68e-06	6.26e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAT—epilepsy syndrome	3.63e-06	6.18e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	3.61e-06	6.15e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	3.58e-06	6.09e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.57e-06	6.08e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	3.56e-06	6.07e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	3.54e-06	6.03e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	3.53e-06	6.01e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	3.41e-06	5.81e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—POMC—epilepsy syndrome	3.35e-06	5.71e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.35e-06	5.7e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.33e-06	5.68e-05	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.29e-06	5.6e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GPX1—epilepsy syndrome	3.28e-06	5.59e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	3.26e-06	5.55e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	3.26e-06	5.54e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.23e-06	5.49e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.23e-06	5.49e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.19e-06	5.43e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.18e-06	5.42e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	3.17e-06	5.39e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	3.16e-06	5.39e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.15e-06	5.36e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TH—epilepsy syndrome	3.14e-06	5.34e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	3.11e-06	5.29e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	3.08e-06	5.24e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—epilepsy syndrome	3.06e-06	5.2e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	2.99e-06	5.08e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.88e-06	4.91e-05	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.88e-06	4.91e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.88e-06	4.9e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	2.86e-06	4.86e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	2.84e-06	4.83e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.82e-06	4.8e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	2.77e-06	4.72e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	2.76e-06	4.7e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	2.7e-06	4.59e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	2.68e-06	4.56e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	2.67e-06	4.55e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.63e-06	4.48e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.62e-06	4.47e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	2.62e-06	4.46e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.62e-06	4.45e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.58e-06	4.4e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.56e-06	4.37e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.55e-06	4.34e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.51e-06	4.28e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	2.49e-06	4.24e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.44e-06	4.15e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—POMC—epilepsy syndrome	2.42e-06	4.13e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	2.42e-06	4.13e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.41e-06	4.11e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	2.34e-06	3.99e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.34e-06	3.97e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.3e-06	3.92e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.28e-06	3.88e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.21e-06	3.77e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—epilepsy syndrome	2.21e-06	3.76e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.19e-06	3.73e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.18e-06	3.71e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	2.1e-06	3.58e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.08e-06	3.54e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.06e-06	3.5e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TH—epilepsy syndrome	2.05e-06	3.49e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.05e-06	3.49e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.05e-06	3.49e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.01e-06	3.42e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.93e-06	3.29e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.76e-06	3e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.72e-06	2.93e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.71e-06	2.91e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.69e-06	2.87e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.64e-06	2.8e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.57e-06	2.67e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	1.55e-06	2.63e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.53e-06	2.6e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.37e-06	2.34e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	1.34e-06	2.29e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.34e-06	2.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.31e-06	2.23e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.31e-06	2.22e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.13e-06	1.92e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.03e-06	1.75e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	9.72e-07	1.65e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.99e-07	1.53e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.91e-07	1.18e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.52e-07	7.69e-06	CbGpPWpGaD
